Fas and Fas ligand interactions in malignant disease.

Abstract

Apoptosis has been implicated in tumor development and progression. Fas (CD95) and Fas ligand (FasL) are an interacting receptor ligand pair that elicits apoptosis in many cell types. Although originally described as proteins regulating peripheral immune tolerance, accumulating evidence suggests that Fas/FasL may play an important role in carcinogenesis, tumor outgrowth, and metastasis. This review summarizes our current knowledge about the regulation of Fas and FasL expression, Fas signaling, soluble Fas production, the role(s) of Fas and FasL in hematopoietic and non-hematopoietic tumorigenesis and progression, and the potential application of Fas-induced apoptosis in cancer therapy.

• Authors: L Owen-Schaub, H Chan, J C Cusack, J Roth, L L Hill
• Journal: International journal of oncology (Int J Oncol) Vol. 17 Issue 1 Pg. 5-12 (Jul 2000) ISSN: 1019-6439 [Print] Greece
• PMID: 10853011 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review)

Chemical References

• FASLG protein, human
• Fas Ligand Protein
• Membrane Glycoproteins
• fas Receptor

Topics

• Animals
• Apoptosis
• Fas Ligand Protein
• Genetic Therapy
• Humans
• Membrane Glycoproteins (physiology)
• Neoplasms (pathology, physiopathology)
• fas Receptor (physiology)